RUNX1 and systemic lupus erythematosus: ChIP data revealed significantly higher levels of RUNX1 protein binding to the NLRP12 promoter in SLE patient–derived PBMCs than in healthy PBMCs (Figure 3J), which explains why RUNX1-mediated transcriptional suppression causes lower NLRP12 expression in SLE patients.